×
ADVERTISEMENT

JANUARY 19, 2022

Abrocitinib Approved to Treat Severe Atopic Dermatitis

Originally published by our sister publication, Specialty Pharmacy Continuum

The FDA approved a new oral medication for the treatment of moderate to severe atopic dermatitis in adults whose disease has not been adequately controlled with other medications.

ad-article">